KPTI vs MSFT: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Microsoft Corp in 2026
KPTI
Karyopharm Therapeutics Inc
$8.28
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | KPTI | MSFT | Winner |
|---|---|---|---|
| Market Cap | $186.66M | N/A | KPTI |
| P/E Ratio | N/A | 24.04 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | 0.1% | 0.2% | MSFT |
| Gross Margin | 9.9% | 68.6% | MSFT |
Analyze KPTI
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or MSFT a better investment?
Comparing KPTI and MSFT: Karyopharm Therapeutics Inc has a market cap of $186.66M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and MSFT?
KPTI (Karyopharm Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.1% for KPTI.
Which company is more profitable: KPTI or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 9.9% for KPTI.
Which is the larger company: KPTI or MSFT?
Karyopharm Therapeutics Inc (KPTI) is larger with a market cap of $186.66M compared to N/A for MSFT.
Should I buy KPTI or MSFT in 2026?
Both KPTI and MSFT have investment merit. KPTI trades at $8.28 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and MSFT stock?
Key differences: Market Cap ($186.66M vs N/A), P/E Ratio (N/A vs 24.0x), Revenue Growth (0.1% vs 0.2%), Gross Margin (9.9% vs 68.6%).